These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 37013062)

  • 1. Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials.
    Song Y; Bi Z; Liu Y; Qin F; Wei Y; Wei X
    Genes Dis; 2023 Jan; 10(1):76-88. PubMed ID: 37013062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.
    Steelman LS; Franklin RA; Abrams SL; Chappell W; Kempf CR; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo P; Ruvolo V; Evangelisti C; Martelli AM; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1080-94. PubMed ID: 21494257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma.
    Yang S; Liu G
    Oncol Lett; 2017 Mar; 13(3):1041-1047. PubMed ID: 28454211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Roles of targeting Ras/Raf/MEK/ERK signaling pathways in the treatment of esophageal carcinoma].
    Chang YS; Liu JC; Fu HQ; Yu BT; Zou SB; Wu QC; Wan L
    Yao Xue Xue Bao; 2013 May; 48(5):635-41. PubMed ID: 23888683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy.
    Li Q; Li Z; Luo T; Shi H
    Mol Biomed; 2022 Dec; 3(1):47. PubMed ID: 36539659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
    Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
    J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Future targeting of the RAS/RAF/MEK/ERK signaling pathway in oncology: the example of melanoma].
    Favre G
    Bull Acad Natl Med; 2014 Feb; 198(2):321-36; discussion 337-8. PubMed ID: 26263707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
    Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
    Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAF-MEK-ERK pathway in cancer evolution and treatment.
    Ullah R; Yin Q; Snell AH; Wan L
    Semin Cancer Biol; 2022 Oct; 85():123-154. PubMed ID: 33992782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.
    Chang F; Steelman LS; Lee JT; Shelton JG; Navolanic PM; Blalock WL; Franklin RA; McCubrey JA
    Leukemia; 2003 Jul; 17(7):1263-93. PubMed ID: 12835716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation.
    Avery TY; Köhler N; Zeiser R; Brummer T; Ruess DA
    Front Oncol; 2022; 12():931774. PubMed ID: 35965494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.
    Xu J; Pfarr N; Endris V; Mai EK; Md Hanafiah NH; Lehners N; Penzel R; Weichert W; Ho AD; Schirmacher P; Goldschmidt H; Andrulis M; Raab MS
    Oncogenesis; 2017 May; 6(5):e337. PubMed ID: 28504689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK inhibitors and DA-Raf, a dominant-negative antagonist of the Ras-ERK pathway, prevent the migration and invasion of KRAS-mutant cancer cells.
    Matsuda A; Masuzawa R; Takahashi K; Takano K; Endo T
    Cytoskeleton (Hoboken); 2024 Jun; ():. PubMed ID: 38872577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting oncogenic Raf protein-serine/threonine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2018 Sep; 135():239-258. PubMed ID: 30118796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathway crosstalk between Ras/Raf and PI3K in promotion of M-CSF-induced MEK/ERK-mediated osteoclast survival.
    Bradley EW; Ruan MM; Vrable A; Oursler MJ
    J Cell Biochem; 2008 Jul; 104(4):1439-51. PubMed ID: 18275061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin-induced proliferation in thyroid cells is mediated by alphavbeta3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals.
    Illario M; Cavallo AL; Monaco S; Di Vito E; Mueller F; Marzano LA; Troncone G; Fenzi G; Rossi G; Vitale M
    J Clin Endocrinol Metab; 2005 May; 90(5):2865-73. PubMed ID: 15687337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK inhibitors as a novel therapy for neuroblastoma: Their in vitro effects and predicting their efficacy.
    Tanaka T; Higashi M; Kimura K; Wakao J; Fumino S; Iehara T; Hosoi H; Sakai T; Tajiri T
    J Pediatr Surg; 2016 Dec; 51(12):2074-2079. PubMed ID: 27686482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors.
    Yuan X; Tang Z; Du R; Yao Z; Cheung SH; Zhang X; Wei J; Zhao Y; Du Y; Liu Y; Hu X; Gong W; Liu Y; Gao Y; Huang Z; Cao Z; Wei M; Zhou C; Wang L; Rosen N; Smith PD; Luo L
    Mol Oncol; 2020 Aug; 14(8):1833-1849. PubMed ID: 32336014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancers.
    Mazumdar T; Sen B; Wang Y; Peng S; Nicholas C; Glisson BS; Myers JN; Johnson FM
    Anticancer Drugs; 2015 Sep; 26(8):835-42. PubMed ID: 26053277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.